Basics Sagimet Biosciences Inc. Series A IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $112.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 5.03% Avg Daily Range (30 D): $0.16 | 4.56% Avg Daily Range (90 D): $0.16 | 4.50% Institutional Daily Volume Avg Daily Volume: .72M Avg Daily Volume (30 D): 1.26M Avg Daily Volume (90 D): .81M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 142 Avg Trade Size (Sh.) (90 D): 147 Institutional Trades Total Inst.Trades: 52 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $.66M Avg Inst. Trade (90 D): $.66M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.2M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.53M Avg Closing Volume: 580.39K     News Oct 1, 2024 @ 4:05 AM Sagimet Biosciences to Present at the H.C. Wainwri... Source: N/A Jun 6, 2024 @ 9:00 AM Sagimet Biosciences Presents Data from ITT and F3 ... Source: Sagimet Biosciences Inc. May 16, 2024 @ 12:20 PM Alibaba To Rally Over 13%? Here Are 10 Top Analyst... Source: Avi Kapoor May 16, 2024 @ 12:00 PM Sagimet Biosciences to Host Virtual Investor and A... Source: Sagimet Biosciences Inc. May 6, 2024 @ 12:00 PM Sagimet Biosciences Announces Appointment of Thier... Source: Sagimet Biosciences Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.56 $-.5 $-1.45 Diluted EPS $-.56 $-.5 $-1.45 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -18.18M $ -16.2M $ -45.57M Operating Income / Loss $ -19.87M $ -18.2M $ -54.45M Cost of Revenue $ $ $ Net Cash Flow $ M $ -1.17M $ .7M PE Ratio